Literature DB >> 15266665

Chronotherapy of high-dose active Vitamin D(3): is evening dosing preferable?

Cheryl P Sanchez1.   

Abstract

Oral Vitamin D(3) is usually administered to children with chronic renal failure in the morning. Is there enough evidence that evening dosing is more beneficial with respect to suppression of parathyroid hormone and reduction of side effects such as hypercalcemia?

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15266665     DOI： 10.1007/s00467-004-1477-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  11 in total

1.  Reduced risk of hypercalcemia for hemodialysis patients by administering calcitriol at night.

Authors:  K Schaefer; E Umlauf; D von Herrath
Journal:  Am J Kidney Dis       Date:  1992-05       Impact factor: 8.860

2.  Magnesium and calcium mass transfer during continuous ambulatory peritoneal dialysis.

Authors:  A Parker; K D Nolph
Journal:  Trans Am Soc Artif Intern Organs       Date:  1980

3.  Circadian rhythms of blood minerals in humans.

Authors:  M Markowitz; L Rotkin; J F Rosen
Journal:  Science       Date:  1981-08-07       Impact factor: 47.728

4.  Safety and efficacy of pulse and daily calcitriol in patients on CAPD: a randomized trial.

Authors:  S M Moe; M A Kraus; C M Gassensmith; N S Fineberg; F H Gannon; M Peacock
Journal:  Nephrol Dial Transplant       Date:  1998-05       Impact factor: 5.992

5.  Temporal interrelationships between the circadian rhythms of serum parathyroid hormone and calcium concentrations.

Authors:  M E Markowitz; S Arnaud; J F Rosen; M Thorpy; S Laximinarayan
Journal:  J Clin Endocrinol Metab       Date:  1988-11       Impact factor: 5.958

Review 6.  A review of intravenous versus oral vitamin D hormone therapy in hemodialysis patients.

Authors:  R B Mazess; L Elangovan
Journal:  Clin Nephrol       Date:  2003-05       Impact factor: 0.975

7.  Chronotherapy of high-dose active vitamin D3 in haemodialysis patients with secondary hyperparathyroidsm: a repeated dosing study.

Authors:  Shuichi Tsuruoka; Michi Wakaumi; Koichi Sugimoto; Tetsuo Saito; Akio Fujimura
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

8.  The effect of calcium supplementation on the circadian rhythm of bone resorption.

Authors:  A Blumsohn; K Herrington; R A Hannon; P Shao; D R Eyre; R Eastell
Journal:  J Clin Endocrinol Metab       Date:  1994-09       Impact factor: 5.958

9.  The effects of intraperitoneal calcitriol on calcium and parathyroid hormone.

Authors:  J A Delmez; C S Dougan; B K Gearing; M Rothstein; D W Windus; N Rapp; E Slatopolsky
Journal:  Kidney Int       Date:  1987-03       Impact factor: 10.612

10.  Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.

Authors:  J C Chan; M B Kodroff; D M Landwehr
Journal:  Pediatrics       Date:  1981-10       Impact factor: 7.124
View more
  1 in total

1.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.